Skip to content

Depression and Anxiety Reduction Treatment for Suicide

Development and Evaluation of a Brief, Suicide Prevention Intervention Targeting Anxiety and Mood Vulnerabilities

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01941862
Acronym
DARTS
Enrollment
300
Registered
2013-09-13
Start date
2013-11-30
Completion date
2017-09-30
Last updated
2018-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Suicide

Keywords

computerized intervention, cognitive bias modification, anxiety, mood, perceived burdensomeness, thwarted belongingness, suicide, post-traumatic stress disorder

Brief summary

The purpose of this study is to test the effectiveness and usability of multiple computer-based treatments for mood and anxiety relevant risk factors. The target of the treatment is related to cognitive stress, which has been shown to be associated with a variety of negative mental health outcomes such as Post-Traumatic Stress Disorder, suicidal ideation, and substance use disorders.

Detailed description

DARTS is a newly developed computerized treatment targeting specific risk factors associated with suicide, mood, and anxiety symptoms. Eligible individuals will be randomized to one of several conditions. In all conditions, participants will complete various self-report questionnaires and a neurophysiology assessment that involves an EEG. Some participants will also be asked to complete four additional EEG assessments. In addition, all participants will be asked to complete a 1, 3, and 6-month follow-up appointment.

Interventions

BEHAVIORALPsychoeducation and Cognitive Bias Modification

Sponsors

United States Department of Defense
CollaboratorFED
Florida State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* At or above community sample mean on ASI-3 * At or above community sample mean on INQ-R * English speakers * 18 years of age or older

Exclusion criteria

* Significant medical illness * Current substance dependence * Current or past psychotic-spectrum disorders * Uncontrolled bipolar disorder * Serious suicidal intent that warranted immediate treatment

Design outcomes

Primary

MeasureTime frameDescription
Interpersonal Needs Questionnaire (INQ)Month 6 follow-upThe INQ is a 15-item self-report measure of the constructs of thwarted belongingness and perceived burdensomeness as defined by the Interpersonal Theory of Suicide. Van Orden et al. report high internal consistency coefficients for the thwarted belongingness (α=.85) and perceived burdensomeness subscales (α=.89). In support of construct validity, both subscales were found to prospectively predict suicidal ideation.

Secondary

MeasureTime frameDescription
Anxiety Sensitivity Index-3 (ASI-3)Month 6 follow-upThe ASI-3 is an 18-item self-report measure of anxiety sensitivity (AS). This scale was developed to provide a more stable measure of the three most widely recognized AS subfactors (cognitive, social and physical concerns) than the original ASI provides. Each subfactor is represented by six items. The measure has shown good psychometric properties.

Other

MeasureTime frameDescription
Beck Suicide Scale (BSS)Month 6 follow-upThe BSS is a 21-item widely used self-report measure assessing a broad spectrum of behaviors and attitudes related to suicide risk, including suicidal ideation and past suicide attempts. It has demonstrated strong reliability and validity.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026